Colon Neoadjuvant FOLFOXIRI Study
NCT01941641
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
DRUG:
neoadjuvant FOLFOXIRI
DRUG:
Capecitabine
Sponsor
Chinese University of Hong Kong